| Financial Year |
March 31 2023 |
| Monetary Funds |
226,154,839.55 |
| Held-for-trading Financial Assets |
30,377,711.39 |
| Notes Receivable |
200,000.00 |
| Accounts Receivable |
40,992,689.38 |
| Advances to Suppliers |
2,463,996.54 |
| Other Receivables |
18,150,962.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
55,359,514.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,800,695.07 |
| Total Current Assets |
375,500,408.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
59,445,186.96 |
| Investment Properties |
976,910.60 |
| Fixed Assetes |
64,096,623.26 |
| Under-construction Projects |
2,868,234.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
73,838,104.80 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
54,458,913.81 |
| Deferred Income Tax Assets |
56,479,533.88 |
| Other Non-Current Assets |
4,035,398.20 |
| Sub-Total of Non-Current Assets |
545,996,175.23 |
| Total Assets |
921,496,584.12 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
65,706,287.13 |
| Accounts Received In Advance |
2,178,776.08 |
| Employee Compensation Payable |
686,327.87 |
| Taxes Payable |
7,366,711.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,721,834.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,105,955.12 |
| Other Current Liabilities |
5,656,299.66 |
| Sub-Total of Current Liabilities |
195,120,770.04 |
| Long-term Loans |
36,059,899.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
41,110,000.00 |
| Deferred Income Tax Liabilities |
39,630,958.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
144,453,552.12 |
| Total Liabilities |
339,574,322.16 |
| Paid-In Capital(Or Share Stock) |
321,447,910.00 |
| Capital Surplus |
44,894,324.45 |
| Surplus Reserve |
39,202,174.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
181,322,506.80 |
| Minority Stockholder's Interest |
-4,944,654.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
586,866,915.98 |
| Owner's Equity（Stockholder's Equity） |
581,922,261.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
921,496,584.12 |
